Annual Working Capital
$2.16 M
-$18.25 M-89.41%
December 31, 2022
Summary
- As of February 26, 2025, BLPH annual working capital is $2.16 million, with the most recent change of -$18.25 million (-89.41%) on December 31, 2022.
- During the last 3 years, BLPH annual working capital has fallen by -$636.00 thousand (-22.73%).
Performance
BLPH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$3.72 M
-$1.90 M-33.79%
September 30, 2023
Summary
- As of February 26, 2025, BLPH quarterly working capital is $3.72 million, with the most recent change of -$1.90 million (-33.79%) on September 30, 2023.
- Over the past year, BLPH quarterly working capital has dropped by -$3.16 million (-45.89%).
Performance
BLPH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BLPH Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -89.4% | -45.9% |
| 3 y3 years | -22.7% | -45.9% |
| 5 y5 years | -92.4% | -72.4% |
BLPH Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.4% | at low | -81.8% | -41.9% |
| 5 y | 5-year | -94.3% | at low | -93.1% | -41.9% |
| alltime | all time | -94.3% | -675.4% | -93.9% | -434.1% |
Bellerophon Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $3.72 M(-33.8%) |
| Jun 2023 | - | $5.62 M(-46.0%) |
| Mar 2023 | - | $10.41 M(+381.4%) |
| Dec 2022 | $2.16 M(-89.4%) | $2.16 M(-68.6%) |
| Sep 2022 | - | $6.88 M(-40.4%) |
| Jun 2022 | - | $11.54 M(-22.8%) |
| Mar 2022 | - | $14.95 M(-26.7%) |
| Dec 2021 | $20.41 M(-45.8%) | $20.41 M(-17.0%) |
| Sep 2021 | - | $24.59 M(-15.4%) |
| Jun 2021 | - | $29.07 M(-9.5%) |
| Mar 2021 | - | $32.13 M(-14.6%) |
| Dec 2020 | $37.65 M(+1245.5%) | $37.65 M(-17.7%) |
| Sep 2020 | - | $45.72 M(-14.9%) |
| Jun 2020 | - | $53.74 M(+2265.1%) |
| Mar 2020 | - | $2.27 M(-18.8%) |
| Dec 2019 | $2.80 M(-71.6%) | $2.80 M(-58.1%) |
| Sep 2019 | - | $6.67 M(-39.4%) |
| Jun 2019 | - | $11.02 M(-23.9%) |
| Mar 2019 | - | $14.47 M(+46.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $9.86 M(-65.4%) | $9.86 M(-26.8%) |
| Sep 2018 | - | $13.47 M(-31.8%) |
| Jun 2018 | - | $19.75 M(-25.1%) |
| Mar 2018 | - | $26.37 M(-7.5%) |
| Dec 2017 | $28.50 M(+42.4%) | $28.50 M(-13.6%) |
| Sep 2017 | - | $32.98 M(+121.5%) |
| Jun 2017 | - | $14.89 M(-13.4%) |
| Mar 2017 | - | $17.18 M(-14.1%) |
| Dec 2016 | $20.01 M(-6.4%) | $20.01 M(+57.1%) |
| Sep 2016 | - | $12.74 M(+2.6%) |
| Jun 2016 | - | $12.42 M(-21.2%) |
| Mar 2016 | - | $15.76 M(-26.3%) |
| Dec 2015 | $21.38 M(+24.1%) | $21.38 M(-44.1%) |
| Sep 2015 | - | $38.21 M(-23.1%) |
| Jun 2015 | - | $49.71 M(-18.2%) |
| Mar 2015 | - | $60.78 M(+252.8%) |
| Dec 2014 | $17.23 M(-238.5%) | $17.23 M(-38.3%) |
| Sep 2014 | - | $27.91 M(-324.3%) |
| Dec 2013 | -$12.44 M(+14.2%) | -$12.44 M |
| Dec 2012 | -$10.89 M | - |
FAQ
- What is Bellerophon Therapeutics annual working capital?
- What is the all time high annual working capital for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics annual working capital year-on-year change?
- What is Bellerophon Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Bellerophon Therapeutics?
- What is Bellerophon Therapeutics quarterly working capital year-on-year change?
What is Bellerophon Therapeutics annual working capital?
The current annual working capital of BLPH is $2.16 M
What is the all time high annual working capital for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high annual working capital is $37.65 M
What is Bellerophon Therapeutics annual working capital year-on-year change?
Over the past year, BLPH annual working capital has changed by -$18.25 M (-89.41%)
What is Bellerophon Therapeutics quarterly working capital?
The current quarterly working capital of BLPH is $3.72 M
What is the all time high quarterly working capital for Bellerophon Therapeutics?
Bellerophon Therapeutics all-time high quarterly working capital is $60.78 M
What is Bellerophon Therapeutics quarterly working capital year-on-year change?
Over the past year, BLPH quarterly working capital has changed by -$3.16 M (-45.89%)